Luminex Shares Climb 20 Percent | GenomeWeb
Shares of Luminex rose 20 percent for the five-day trading period ended Tuesday. The firm did not report any news or US Securities and Exchange Commission filings since it reported second-quarter results two weeks ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.